日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations.

新型纯αVβ3整合素拮抗剂,低浓度下不诱导受体延伸、启动受体或增强血管生成

Li Jihong, Fukase Yoshiyuki, Shang Yi, Zou Wei, Muñoz-Félix José M, Buitrago Lorena, van Agthoven Johannes, Zhang Yixiao, Hara Ryoma, Tanaka Yuta, Okamoto Rei, Yasui Takeshi, Nakahata Takashi, Imaeda Toshihiro, Aso Kazuyoshi, Zhou Yuchen, Locuson Charles, Nesic Dragana, Duggan Mark, Takagi Junichi, Vaughan Roger D, Walz Thomas, Hodivala-Dilke Kairbaan, Teitelbaum Steven L, Arnaout M Amin, Filizola Marta, Foley Michael A, Coller Barry S

Discovery and Optimization of Potent and CNS Penetrant M(5)-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold

发现和优化源自新型手性N-(茚满基)哌啶酰胺骨架的高效且具有中枢神经系统穿透性的M(5)优先正向变构调节剂

Bender, Aaron M; Cho, Hyekyung P; Nance, Kellie D; Lingenfelter, Kaelyn S; Luscombe, Vincent B; Gentry, Patrick R; Voigtritter, Karl; Berizzi, Alice E; Sexton, Patrick M; Langmead, Christopher J; Christopoulos, Arthur; Locuson, Charles W; Bridges, Thomas M; Chang, Sichen; O'Neill, Jordan C; Zhan, Xiaoyan; Niswender, Colleen M; Jones, Carrie K; Conn, P Jeffrey; Lindsley, Craig W

Subcutaneous meloxicam suspension pharmacokinetics in mice and dose considerations for postoperative analgesia

小鼠皮下注射美洛昔康混悬液的药代动力学及术后镇痛的剂量考虑

Chen, Patty H; Boyd, Kelli L; Fickle, Erin K; Locuson, Charles W

Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporter

合成一系列4-甲氧基-3-(哌啶-4-基)氧基苯甲酰胺类化合物及其作为突触前胆碱转运蛋白新型抑制剂的构效关系

Bollinger, Sean R; Engers, Darren W; Ennis, Elizabeth A; Wright, Jane; Locuson, Charles W; Lindsley, Craig W; Blakely, Randy D; Hopkins, Corey R

Discovery of a highly selective PLD2 inhibitor (ML395): a new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strains

发现一种高选择性PLD2抑制剂(ML395):一种具有改进的理化性质和广谱抗流感病毒活性的新型探针

O'Reilly, Matthew C; Oguin, Thomas H 3rd; Scott, Sarah A; Thomas, Paul G; Locuson, Charles W; Morrison, Ryan D; Daniels, J Scott; Brown, H Alex; Lindsley, Craig W

Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354

取代吲哚类化合物作为选择性蛋白酶激活受体4 (PAR-4) 拮抗剂:ML354 的发现和构效关系研究

Wen, Wandong; Young, Summer E; Duvernay, Matthew T; Schulte, Michael L; Nance, Kellie D; Melancon, Bruce J; Engers, Julie; Locuson, Charles W 2nd; Wood, Michael R; Daniels, J Scott; Wu, Wenjun; Lindsley, Craig W; Hamm, Heidi E; Stauffer, Shaun R

Preparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9

金固定化细胞色素P450 2C9的制备、表征和底物代谢

Gannett, Peter M; Kabulski, Jarod; Perez, Felio A; Liu, Zhongyuan; Lederman, David; Locuson, Charles W; Ayscue, Robyn R; Thomsen, Nissa M; Tracy, Timothy S